blog

GDPR: Its Intent – and Its Integrity

By Rob Laurens on Wed, May 23, 2018

There are probably a good number of us in the clinical research and development industry that are spending a lot of time dotting the i’s and crossing the t’s on their Privacy Policies and otherwise ensuring that everything is ready for the 25th of May, the day that the EU’s General Data Protection Regulation (GDPR) goes into effect. And, there are probably a good number of us who have had a rather intense schedule over the past few months. But, I bet if you conducted a poll, you’d find that despite all the time-consuming work and activity, those of us concerned with the patient experience are greatly pleased that GDPR is finally here.

International Clinical Trials Day: Of Limes, Lemons, and the Fruits of Our Labor

By Rob Laurens on Tue, May 20, 2014

On this day in 1747, James Lind, a Scottish physician, began what is now generally recognized as the first clinical trial. Among other things, his study of British sailors would provide evidence via a systematic experiment that scurvy could be treated by eating citrus fruits. While it had been generally recognized since antiquity in some parts of the world that citrus staved off this seaman's scourge, Lind's work contributed to creating a more systematic means of helping to ensure the health of the Royal Navy. In turn, one could argue Lind's experiment helped enable Britannia to rule the waves – and thereby European politics – for quite some time to come.

Topics: Patient Recruitment, Patient Advocacy

It’s Rare Disease Day®: Join Together for Better Care

By Rob Laurens on Fri, Feb 28, 2014

As a patient recruitment company, it’s elementary (though not always obvious to the casual observer) that, with extremely few exceptions, we deal only with the hard-to-enroll studies. Further, it’s not out of the ordinary for us to tackle the (seemingly) impossible-to-enroll studies. So, rare diseases are not uncommon to us, being that they often fall into the latter category of recruit-ability. Indeed, BBK Worldwide (BBK) has had a great deal of experience with rare disease studies. And, if there’s such a thing as a therapeutic category that inspires us more than any other, it’s this one.

Topics: BBK Worldwide, Patient Recruitment, Technology

Is Amending the Patients’ Bill of Rights in Our Future? - Part Two

By Rob Laurens on Fri, Dec 20, 2013

In the first part of this blog, we looked at how various Patients’ Bills of Rights – whether created by a state or by a health institution – have handled the idea of patients and clinical research. In this part, we pick up with questions related to the idea of ensuring patients are told about clinical trials for which they may be eligible.

Topics: Patient Recruitment, Disruptive Innovation

Is Amending the Patients’ Bill of Rights in Our Future? - Part One

By Rob Laurens on Wed, Dec 18, 2013

This is the first of a two-part blog that looks at the extent to which a patient’s rights can and should include access to information about clinical trials for which they may be eligible.

Topics: Patient Recruitment, Disruptive Innovation

Changing the Subject: Patient Retention and the Humanization of Medicine

By Rob Laurens on Wed, Aug 28, 2013

I was in the dentist’s office this morning, waiting my turn, leafing through a copy of Smithsonian magazine, the July-August 2013 issue. I came across a short piece on page 20 that got me thinking about a number of things – including clinical trial patient retention.

Topics: Patient Retention, Patient Advocacy

Part 2: Maximizing Positive Trends in Global Patient Recruitment, Time: Your Most Valuable Asset

By Rob Laurens on Fri, May 3, 2013

In part one of this two-part series, I discussed positive trends in patient recruitment and how the sheer range of recruitment- and retention-related services, products, and solutions has exponentially increased, with innovation never stronger. While today’s trends in global patient recruitment are creating the opportunity for greater momentum than ever before, it’s important to strategically consider tactics based on site capabilities and the unique study at hand. How do you do this?

Topics: Patient Retention, Patient Recruitment

Part 1: Maximizing Positive Trends in Global Patient Recruitment

By Rob Laurens on Fri, Apr 26, 2013

Today’s trends in global patient recruitment are creating the opportunity for greater momentum than ever before. However, it’s important to strategically use only the campaign tactics that bring the greatest value based on site capabilities and the unique study at hand. In part one of Rob’s two-part blog series, he considers today’s positive trends. Look for part two of this series next week where Rob will discuss how best to maximize these trends.

Topics: Patient Recruitment, Patient Advocacy, Social Media, Technology, Trends

Avoiding Headaches in IRB and EC Submissions and Approvals

By Rob Laurens on Thu, Mar 7, 2013

Delays in your IRB or EC submission and review process can not only cause severe headaches for your clinical team members, they can wreak havoc on your patient recruitment campaign’s critical path. Or perhaps better said, an efficient IRB / EC submission management process can mean the difference between maximizing the return on your recruitment investment and your campaign being too little, too late to significantly affect your enrollment completion date.
Here are five basic tips that will help ensure your regulatory body submissions of patient recruitment materials are easy, exacting, and expedited: 

Topics: BBK Worldwide, Patient Recruitment, Cultural Adaptation, Patient Advocacy

Meet the Newest BBK Employees!

By Rob Laurens on Fri, Aug 24, 2012

It’s time to meet the BBK Worldwide newbies! Aside from all the basic HR processes, and corporate programs BBK newcomers need to learn, the most important part of their initiation to the company is to write a blog. So let’s meet our newest employees at BBK as they embark on an incredible adventure in patient recruitment.

Topics: BBK Worldwide

 
Subscribe To Our Blog